News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LOLLINI ROBERT J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2011 |
4
| LOLLINI ROBERT J (President and CEO) has filed a Form 4 on Myrexis, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2.75, valued at
$825k
|
|
| 09/28/2010 |
4
| LOLLINI ROBERT J (CFO) has filed a Form 4 on Myrexis, Inc.|
Txns:
| Granted 22,167 shares
@ $0
Granted 66,500 options to buy
@ $3.86, valued at
$256.7k
|
|
| 02/22/2010 |
4
| LOLLINI ROBERT J (CFO) has filed a Form 4 on Myriad Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $4.83, valued at
$159.4k
|
|
| 09/14/2009 |
4/A
| LOLLINI ROBERT J (CFO) has filed a Form 4 on Myriad Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $4.63, valued at
$152.8k
|
|
| 09/14/2009 |
4
| LOLLINI ROBERT J (CFO) has filed a Form 4 on Myriad Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 options to buy
@ $4.63, valued at
$152.8k
|
|
| 07/06/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/11/2009 |
3
| LOLLINI ROBERT J (CFO) has filed a Form 3 on Myriad Pharmaceuticals, Inc. |
|
|